T-lymphocyte activation antigen CD80 (B7-1) and T-cell-specific surface glycoprotein CD28 complex (CD80-CD28 complex)

The B7.1 (CD80) – CD28 costimulatory receptor complex is a fundamental molecular bridge between antigen-presenting cells (APCs) and T-lymphocytes, serving as the primary "Signal 2" required for full T-cell activation [UniProt P33681, UniProt P16410]. B7.1 is a member of the immunoglobulin superfamily expressed on activated B cells, macrophages, and dendritic cells, while CD28 is its cognate receptor constitutively expressed on most T cells [StatPearls NBK542180]. Upon binding, this complex initiates downstream signaling through the PI3K and Grb2/SOS pathways, which promotes T-cell survival, metabolic reprogramming, and the secretion of interleukin-2 (IL-2) [UniProt P16410, StatPearls NBK542180]. In the absence of this costimulatory signal, T-cell receptor (TCR) engagement alone often leads to anergy or apoptosis, making this complex a critical checkpoint for immune tolerance [StatPearls NBK542180]. Pathologically, overactivity of this pathway contributes to the pathogenesis of autoimmune diseases like rheumatoid arthritis and the rejection of transplanted organs [FDA Label: Orencia]. Therapeutic agents such as abatacept and belatacept are engineered CTLA-4-Ig fusion proteins that bind to B7.1 with high affinity, effectively masking it and preventing its interaction with CD28 to suppress unwanted immune responses [FDA Label: Orencia, PubMed 21642915]. Conversely, historical attempts to directly stimulate CD28 with superagonistic antibodies like TGN1412 resulted in catastrophic systemic inflammation, highlighting the potent and sensitive nature of this signaling axis [NEJM 355:1018-1028].

Other names

B7-1-CD28 complexCD80-CD28 interactionB7.1-CD28 costimulatory pathwayCluster of Differentiation 80 and Cluster of Differentiation 28 complex

Competitive inhibition of the CD80/CD86-CD28 interaction by CTLA-4-Ig fusion proteins to prevent T-cell costimulation; direct agonism of CD28 to induce T-cell activation.